Overview

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and commercialize them. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. Unlike many competitors, Takeda emphasizes patient-centric values, ensuring that patient needs guide their operations. The company aims to launch up to 15 new products by FY2024 and has a strong pipeline of 11 NMEs. Additionally, Takeda is committed to environmental sustainability, recognizing the connection between environmental health and human health.

💡 Want to apply to Takeda?

You have ways to get a Takeda referral from your network.

Get referrals →

Simplify's Take

What believers are saying

• Takeda's collaboration with BridGene is worth up to $770 million.
• The company is expanding its market presence in emerging Asian economies.
• Takeda's focus on personalized medicine aligns with industry trends.

What critics are saying

• Antitrust litigation over Amitiza could harm Takeda's reputation and finances.
• A data breach incident poses significant cybersecurity and legal risks.
• The telehealth market's rapid changes may affect Takeda's investment in American Well.

What makes Takeda unique

• Takeda has a 240-year history in the biopharmaceutical industry.
• The company emphasizes patient-centric values in its operations.
• Takeda has a robust pipeline with 11 NMEs and aims for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

YesNo